Porcilis M Hyo

Description and Vaccination Program

Active ingredients
Inactivated whole-cell concentrate of Mycoplasma hyopneumoniae strain 11 incorporated in an adjuvant based on dl-α-tocopherol acetate (Diluvac Forte) to prolong immune stimulation. Each dose contains ≥ 2^7.0 Ab titre*.
* Mean antibody titre (Ab) obtained after inoculation of mice with a 1/20th of a pig dose.

Indication
For the active immunisation of (finishing) pigs to reduce pulmonary lesions due to infection by Mycoplasma hyopneumoniae .

Vaccination program
Two doses with a three week interval between, beginning as early as 1 week of age.

Published data has shown that the efficacy of Porcilis PRRS and Porcilis M Hyo is equal whether given individually or both at the same time.

Immunity
Onset of immunity: 2 weeks after the second dose.
Duration of immunity: At least 20 weeks after the second dose.

Dosage and method of administration
Each dose: 2ml by intramuscular injection in the neck, behind the ear.

Pharmaceutical precautions

• Store between +2°C and +8°C. Do not freeze.
• Allow the vaccine to reach room temperature (15-25°C) before use.
• Shake well before use.

Presentation
Porcilis M Hyo is available in 10, 50 and 100 dose presentations.
Not all pack sizes may be marketed in all countries.

Our family of registered products differs from country to country. Please contact your local MSD/Merck Animal Health contact person for country specific product registrations and product availability.

Porcilis M hyo

Vaccinator